NCT00326235View on ClinicalTrials.gov

Effects of Buspirone in Opiate Withdrawal

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2002

Study Completion Date

July 31, 2004

Conditions

Heroin Dependence

Interventions

DRUG

Buspirone

Trial Locations (1)

11209

VA New York Harbor Healthcare System - Brooklyn Campus, Brooklyn

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00326235 - Effects of Buspirone in Opiate Withdrawal | Biotech Hunter | Biotech Hunter